1,317 Shares in The Cigna Group (NYSE:CI) Acquired by Genesis Private Wealth LLC

Genesis Private Wealth LLC bought a new stake in shares of The Cigna Group (NYSE:CI) in the fourth quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor bought 1,317 shares of the health services provider’s stock, valued at approximately $364,000.

Several other large investors also recently modified their holdings of CI. ORG Wealth Partners LLC bought a new stake in The Cigna Group during the fourth quarter worth $34,000. Ulland Investment Advisors LLC lifted its position in shares of The Cigna Group by 2,500.0% during the 3rd quarter. Ulland Investment Advisors LLC now owns 104 shares of the health services provider’s stock worth $36,000 after buying an additional 100 shares during the last quarter. Prospera Private Wealth LLC acquired a new stake in The Cigna Group in the third quarter valued at about $37,000. Harbor Capital Advisors Inc. bought a new position in The Cigna Group in the third quarter valued at about $45,000. Finally, Intact Investment Management Inc. acquired a new position in The Cigna Group during the third quarter worth about $69,000. 86.99% of the stock is owned by institutional investors and hedge funds.

Wall Street Analyst Weigh In

Several equities research analysts recently issued reports on CI shares. Truist Financial decreased their price target on shares of The Cigna Group from $420.00 to $390.00 and set a “buy” rating on the stock in a report on Monday, January 6th. Royal Bank of Canada dropped their price target on The Cigna Group from $384.00 to $377.00 and set an “outperform” rating for the company in a research note on Friday, November 1st. Cantor Fitzgerald restated an “overweight” rating and set a $400.00 price objective on shares of The Cigna Group in a research report on Wednesday, October 23rd. StockNews.com downgraded The Cigna Group from a “strong-buy” rating to a “buy” rating in a research report on Monday, November 4th. Finally, Barclays boosted their price target on The Cigna Group from $405.00 to $420.00 and gave the stock an “overweight” rating in a report on Tuesday, November 5th. One equities research analyst has rated the stock with a hold rating, fourteen have given a buy rating and one has issued a strong buy rating to the company. According to MarketBeat.com, The Cigna Group currently has a consensus rating of “Buy” and a consensus target price of $395.93.

The Cigna Group Stock Performance

Shares of The Cigna Group stock opened at $288.48 on Wednesday. The Cigna Group has a 52 week low of $262.03 and a 52 week high of $370.83. The company has a quick ratio of 0.72, a current ratio of 0.72 and a debt-to-equity ratio of 0.71. The business has a 50 day moving average price of $300.19 and a 200-day moving average price of $326.51. The company has a market cap of $80.24 billion, a PE ratio of 27.21, a price-to-earnings-growth ratio of 0.77 and a beta of 0.54.

The Cigna Group (NYSE:CI) last issued its quarterly earnings data on Thursday, October 31st. The health services provider reported $7.51 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $7.22 by $0.29. The Cigna Group had a net margin of 1.31% and a return on equity of 18.42%. The business had revenue of $63.70 billion during the quarter, compared to the consensus estimate of $59.58 billion. During the same period in the prior year, the firm posted $6.77 EPS. The firm’s quarterly revenue was up 29.8% compared to the same quarter last year. Equities analysts anticipate that The Cigna Group will post 28.5 earnings per share for the current fiscal year.

The Cigna Group Company Profile

The Cigna Group, together with its subsidiaries, provides insurance and related products and services in the United States. Its Evernorth Health Services segment provides a range of coordinated and point solution health services, including pharmacy benefits, home delivery pharmacy, specialty pharmacy, distribution, and care delivery and management solutions to health plans, employers, government organizations, and health care providers.